EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Herpes zoster infection and myocardial infarction risk: Evaluating the impact of antiviral therapy in a nationwide self-controlled case series study

Hsi-Yu Lai, Lin-Chieh Meng, Ho-Min Chen, Hui-Min Chuang, Liang-Kung Chen, Fei-Yuan Hsiao

Journal of Infection and Public Health · 2026-01 · 19 (1) · 103008

DOI: 10.1016/j.jiph.2025.103008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Infection and Public Health, 2026-01. Verfasst von Hsi-Yu Lai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan; Health Data Research Center, National Taiwa…. Hauptthemen laut MEDLINE: Herpes Zoster, Myocardial Infarction, Antiviral Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Executive Yuan Republic of China Ministry of Education, Ministry of Science and Technology, Taiwan, National Yang Ming Chiao Tung University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: While herpes zoster (HZ) has been associated with increased cardiovascular risk, the temporal relationship between HZ and myocardial infarction (MI) and whether antiviral therapy modifies this risk remain incompletely understood. METHODS: We employed a self-controlled case series design that controls for time-invariant confounding by using patients as their own controls. Using Taiwan's National Health Insurance Database, we analyzed 4215 patients with both HZ and MI diagnoses (mean age 68.9 ± 12.6 years). We compared MI incidence across different time periods relative to HZ diagnosis using conditional Poisson regression, adjusting for age, gender, and antiviral use. RESULTS: The study population had a mean age of 68.9 ± 12.6 years, with 67 % being male and 76.5 % aged 60 years or older. The MI incidence per 100 person-years increased from 25.89 (95 % confidence interval (CI): 25.43-26.35) during the reference period to 39.99 (95 % CI: 33.86-47.21) in the 1-4 week risk period following HZ diagnosis (adjusted incidence rate ratio (IRR): 1.53, 95 % CI: 1.29-1.82). Importantly, subgroup analyses revealed this elevated risk persisted in both antiviral users (IRR: 1.71, 95 % CI: 1.36-2.16) and non-users (IRR: 1.36, 95 % CI: 1.06-1.76), suggesting antiviral therapy does not mitigate the increased cardiovascular risk. MI risk during the pre-exposure period was slightly elevated but not statistically significant (IRR: 1.20, 95 % CI: 0.99-1.46), suggesting the possibility of shared predisposing factors. CONCLUSION: HZ is associated with significantly increased MI risk during the month following diagnosis, regardless of antiviral treatment. These findings provide important new evidence regarding the relationship between antiviral therapy and cardiovascular outcomes in HZ patients and suggest that cardiovascular monitoring should be considered for all HZ patients in the acute phase, irrespective of treatment status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpes ZosterMyocardial InfarctionAntiviral AgentsHumansMaleFemaleAgedMiddle AgedTaiwanIncidenceAged, 80 and overRisk Factors

Stichwörter der Autor:innen

Antiviral therapyCardiovascular riskHerpes zosterMyocardial infarctionSelf-controlled case series

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan; Health Data Research Center, National Taiwan University, Taipei, Taiwan.
  • Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan; Health Data Research Center, National Taiwan University, Taipei, Taiwan; Department of Biostatistics, Epidemiolog…
  • Health Data Research Center, National Taiwan University, Taipei, Taiwan.
  • Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, Taipei, Taiwan; Taipei Municipal Gan-Da…
  • Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Pharmacy, Nati…

Förderung

  • Executive Yuan Republic of China Ministry of Education
  • Ministry of Science and Technology, Taiwan
  • National Yang Ming Chiao Tung University
  • National Science and Technology Council

Zitieren

APA

Lai, H. Y., Meng, L. C., Chen, H. M., Chuang, H. M., Chen, L. K., & Hsiao, F. Y. (2026). Herpes zoster infection and myocardial infarction risk: Evaluating the impact of antiviral therapy in a nationwide self-controlled case series study. Journal of Infection and Public Health, 19(1), 103008. https://doi.org/10.1016/j.jiph.2025.103008

Vancouver

Lai HY, Meng LC, Chen HM, Chuang HM, Chen LK, Hsiao FY. Herpes zoster infection and myocardial infarction risk: Evaluating the impact of antiviral therapy in a nationwide self-controlled case series study. Journal of Infection and Public Health. 2026;19(1):103008. doi:10.1016/j.jiph.2025.103008

BibTeX
@article{Lai2026,
  author = {Lai, Hsi-Yu and Meng, Lin-Chieh and Chen, Ho-Min and Chuang, Hui-Min and Chen, Liang-Kung and Hsiao, Fei-Yuan},
  title = {Herpes zoster infection and myocardial infarction risk: Evaluating the impact of antiviral therapy in a nationwide self-controlled case series study},
  journal = {Journal of Infection and Public Health},
  year = {2026},
  volume = {19},
  number = {1},
  pages = {103008},
  doi = {10.1016/j.jiph.2025.103008}
}
Kostenlos starten →